The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
Open accessAbstract
Tangier disease is a rare genetic disorder characterized by extremely low plasma levels of HDL and apo A-I, deposition of cholesteryl esters in tissues, and a high prevalence of cardiovascular disease. We examined the possibility that HDL apolipoprotein-mediated removal of cellular lipids may be defective in Tangier disease. With fibroblasts from normal subjects, purified apo A-I cleared cells of cholesteryl esters, depleted cellular free cholesterol pools available for esterification, and stimulated efflux of radiolabeled cholesterol, phosphatidylcholine, and sphingomyelin. With fibroblasts from two unrelated Tangier patients, however, apo A-I had little or no effect on any of these lipid transport processes. Intact HDL also was unable to clear cholesteryl esters from Tangier cells even though it promoted radiolabeled cholesterol efflux to levels 50-70% normal. Passive desorption of radiolabeled cholesterol or phospholipids into medium containing albumin or trypsinized HDL was normal for Tangier cells. Binding studies showed that the interaction of apo A-I with high-affinity binding sites on Tangier fibroblasts was abnormal. These results indicate that apo A-I has an impaired ability to remove cholesterol and phospholipid from Tangier fibroblasts, possibly because of a defective interaction of apo A-I with cell-surface binding sites. Failure of apo A-I to acquire cellular lipids may account for the rapid catabolism of nascent HDL particles and the low plasma HDL levels in Tangier disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 642
Assay of inorganic and organic phosphorus in the 0.1–5 nanomole range
Hess, H. H., & Derr, J. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90388-7 · Cited by 440
Eisenberg, S., Bilheimer, D. W., & Levy, R. I. (1972) · PubMed · Cited by 431
Hara, H., & Yokoyama, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49957-7 · Cited by 331
Homozygous Tangier disease and cardiovascular disease
Serfaty-Lacrosniere, C., Civeira, F., Lanzberg, A., Isaia, P., Berg, J., Janus, E. D., Smith, M. P., Pritchard, P. H., Frohlich, J., Lees, R. S., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90144-9 · Cited by 262
Mendez, A. J., Oram, J. F., & Bierman, E. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99196-9 · Cited by 256
Self-citationHorowitz, B. S., Goldberg, I. J., Merab, J., Vanni, T. M., Ramakrishnan, R., & Ginsberg, H. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116384 · Cited by 231
Graham, D. L., & Oram, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47584-9 · Cited by 214
Self-citationMendez, A. J., Anantharamaiah, G. M., Segrest, J. P., & Oram, J. F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117515 · Cited by 189
Self-citationHuang, Y., von Eckardstein, A., Wu, S., Maeda, N., & Assmann, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1834 · Cited by 181
The Inheritance of High Density Lipoprotein Deficiency (Tangier Disease)*
Fredrickson, D. S. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104907 · Cited by 163
McKnight, G. L., Reasoner, J., Gilbert, T., Sundquist, K. O., Hokland, B., McKernan, P. A., Champagne, J., Johnson, C. J., Bailey, M. C., & Holly, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49815-3 · Cited by 158
Oram, J. F., Mendez, A. J., Slotte, J. P., & Johnson, T. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.403 · Cited by 149
Self-citationThe metabolism of very low density lipoprotein proteins
Eisenberg, S., Bilheimer, D. W., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90216-0 · Cited by 143
Bielicki, J., Johnson, W., Weinberg, R., Glick, J. M., & Rothblat, G. H. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41392-6 · Cited by 126
Forte, T., Regine Goth-goldstein, A., Nordhausen, R. W., & McCall, M. R. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40758-8 · Cited by 118
Tangier disease: a disorder of intracellular membrane traffic.
Schmitz, G., Assmann, G., Robenek, H., & Brennhausen, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6305 · Cited by 113
Aviram, M., Bierman, E. L., & Oram, J. F. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38399-1 · Cited by 101
Self-citationHitoshi, H., & Yokoyama, S. (1992) · Biochemistry · doi:10.1021/bi00122a021 · Cited by 94
Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins
Oram, J. F. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29096-5 · Cited by 92
Self-citationWalter, M., Gerdes, U., Seedorf, U., & Assmann, G. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2742 · Cited by 79
α‐Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux
Hara, H., Hara, H., Komaba, A., & Yokoyama, S. (1992) · Lipids · doi:10.1007/bf02536480 · Cited by 66
In vivo metabolism of proapolipoprotein A-I in Tangier disease.
Bojanovski, D., Gregg, R. E., Zech, L. A., Meng, M. S., Bishop, C., Ronan, R., & Brewer, H. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113266 · Cited by 61
Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
Bojanovski, D., Gregg, R. E., & Brewer, H. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82101-2 · Cited by 43
Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages.
Schmitz, G., Fischer, H., Beuck, M., Hoecker, K. P., & Robenek, H. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.6.1010 · Cited by 42
Abnormal processing of Golgi elements and lysosomes in Tangier disease.
Robenek, H., & Schmitz, G. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1007 · Cited by 38
Tangier disease. The complete mRNA sequence encoding for preproapo-A-I.
Law, S. W. T., & Brewer, H. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38949-4 · Cited by 33
Human proapoA-ITangier: Isolation of proapoA-ITangier and amino acid sequence of the propeptide
Brewer, H. B., Fairwell, T., Meng, M., Kay, L. L., & Ronan, R. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91088-4 · Cited by 31
Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease.
Frohlich, J., Fong, B., Julien, P., Després, J., Ángel, A., Hayden, M. R., McLeod, R. S., Chow, C. K., Davison, R. H., & Pritchard, H. (1987) · PubMed · Cited by 13
Cited by
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
Costet, P., Luo, Y., Wang, N., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003337200 · Cited by 979
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Metadata
- Authors
- Francis, G. A., Knopp, R. H., & Oram, J. F.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-07-01
- Volume
- 96
- Issue
- 1
- Pages
- 78-87
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2009832539
- Cited by
- 424
- References
- 36
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.